Clinical Trials · NCT03936218
Goserelin 10.8mg Injection in Treatment of Advanced Prostate Cancer
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Eurofarma Laboratorios S.A.
- Enrollment
- 94
- Start date
- Sep 2020
- Locations
- 1 site, India
- Primary endpoint
- To evaluate and compare the pharmacodynamics of test product against reference product and establish non inferiority.